Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
102.19
+0.45 (+0.44%)
Official Closing Price
Updated: 7:00 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
30
31
Next >
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
May 05, 2023
Via
Benzinga
Is Dexcom a Good Stock to Buy Now?
May 02, 2023
A poorly received first-quarter earnings report has investors wondering if this stock's best days are behind it.
Via
The Motley Fool
3 Stocks to Buy Before They Soar to New Heights in 2023
May 01, 2023
Here are three stocks to buy, for investors looking for companies on the cusp of a potential breakout driven by secular growth catalysts.
Via
InvestorPlace
Looking At Abbott Laboratories's Recent Unusual Options Activity
April 28, 2023
Via
Benzinga
Got $1,000? 2 Top Dividend Stocks to Buy Now
April 28, 2023
Passive income can add to your stock market winnings.
Via
The Motley Fool
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
April 27, 2023
Via
Benzinga
Why Abbott Laboratories Stock Looks Ridiculously Overpriced
April 27, 2023
Abbott's stock is trading at a huge premium, and it isn't a justifiable one for investors.
Via
The Motley Fool
Is Abbott Laboratories Stock a Buy for Dividend Investors?
April 25, 2023
This healthcare company stands out among its peers as a Dividend King.
Via
The Motley Fool
Abbott Laboratories Unusual Options Activity
April 21, 2023
Via
Benzinga
P/E Ratio Insights for Abbott Laboratories
April 21, 2023
Via
Benzinga
Check Out What Whales Are Doing With ABT
April 19, 2023
Via
Benzinga
7 Healthcare Stocks With Huge Return Potential for Long-Term Investors
April 27, 2023
These leading healthcare companies have proven that they can deliver reliable gains to their shareholders over many years and decades.
Via
InvestorPlace
The Fed Predicts a Recession: Should You Still Buy Stocks Now?
April 25, 2023
The Fed expects a "mild" downturn.
Via
The Motley Fool
Sleep Easy With These 2 Rock-Solid Dividend Stocks
April 25, 2023
They aren't in any danger of crimping their dividends.
Via
The Motley Fool
This Supercharged Dividend King Stock Might Soon Run Out of Steam
April 25, 2023
Emerging competitive threats in immunology, oncology, and medical aesthetics, along with a highly leveraged balance sheet, might dampen the drugmaker's growth trajectory post-2025.
Via
The Motley Fool
This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health
April 25, 2023
The need for noninvasive healthcare technology that allows people to take ownership and gather more insight into their health became acute when COVID revealed the fragility of the hospital system.
Via
Benzinga
Why Abbott Laboratories Shares Are Trading Higher Today?
April 19, 2023
Via
Benzinga
Abbott Labs Shakes Off Covid Test Decline To Top First-Quarter Estimates
April 19, 2023
Covid tests are still expected to bring in $1.5 billion in sales this year.
Via
Investor's Business Daily
Is Abbott Laboratories Still a Good Dividend Stock to Buy?
April 23, 2023
A better-than-expected first-quarter report already pushed it much higher.
Via
The Motley Fool
Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review
April 21, 2023
The major indexes saw modest declines, holding in a range.
Via
Investor's Business Daily
Healthcare Sector Update: MedTech Trending Up
April 20, 2023
Earnings from major device companies and large-cap biopharma over the next two weeks will help us ascertain risks for the market.
Via
Talk Markets
Abbott Laboratories To Rally 17%? Here Are 10 Other Analyst Forecasts For Thursday
April 20, 2023
Morgan Stanley cut the price target for Charter Communications, Inc. (NASDAQ: CHTR) from $460 to $420. Morgan Stanley analyst Benjamin Swinburne maintained an Equal-Weight rating. Charter...
Via
Benzinga
CBOE Volatility Index Drops To Lowest Level Since November 2021; S&P 500 Ends Almost Flat
April 20, 2023
The S&P 500 closed almost flat on Wednesday following the release of corporate earnings.
Via
Benzinga
Tesla, Rivian, IBM, Zions, Lam Research: Why These Five Stocks Are Drawing Investors' Attention Today
April 19, 2023
Via
Benzinga
Why Medtronic Stock Soared More Than 4% Higher Today
April 19, 2023
The veteran device maker did well on a very good day for stocks in its industry.
Via
The Motley Fool
Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results
April 19, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Wednesday. The Dow traded down 0.23% to 33,899.20 while the NASDAQ rose 0.16% to 12,172.92. The S&P 500,...
Via
Benzinga
Abbott's Q1 Earnings Beat Estimates, Margins Down
April 19, 2023
Abbott Laboratories reported first-quarter 2023 adjusted earnings of $1.03 per share.
Via
Talk Markets
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 19, 2023
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.
Via
Benzinga
Meta Prepares For Further Job Cuts, Google To Allow Developers To Use Alternative Payment Options, Intel Ditches Production Of Bitcoin Mining Chip: Today's Top Stories
April 19, 2023
Bloomberg
Via
Benzinga
2 Stocks That Could Help Make You a Millionaire by Retirement
April 19, 2023
These companies are accustomed to delivering excellent returns.
Via
The Motley Fool
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.